(Q50539356)

15 March 2018

title

Advanced glycation end products (AGEs) increase human mesangial foam cell formation by increasing Golgi SCAP glycosylation in vitro. (English)

1 reference

15 March 2018

1 reference

Yang Yuan

1

1 reference

15 March 2018

Lei Zhao

2

1 reference

15 March 2018

Yaxi Chen

3

1 reference

15 March 2018

John F Moorhead

4

1 reference

15 March 2018

Zac Varghese

5

1 reference

15 March 2018

Stephen H Powis

6

1 reference

15 March 2018

Shane Minogue

7

1 reference

15 March 2018

Zilin Sun

8

1 reference

15 March 2018

Xiong Z Ruan

9

1 reference

15 March 2018

publication date

20 April 2011

1 reference

15 March 2018

American Journal of Physiology - Renal Physiology

published in

1 reference

15 March 2018

volume

301

1 reference

15 March 2018

issue

1

1 reference

15 March 2018

page(s)

F236-43

1 reference

15 March 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Atherosclerosis. Scavenging for receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Accumulation of Maillard reaction products in skin collagen in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Protein sensors for membrane sterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Diabetes, hemoglobin A(1c), cholesterol, and the risk of moderate chronic renal insufficiency in an ambulatory population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Oxidized LDL through LOX-1 modulates LDL-receptor expression in human coronary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Glycosidase inhibitors in study of glycoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Assembly of asparagine-linked oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Apolipoprotein E genotype and plasma lipid levels in Caucasian diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Relation between serum cholesterol and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Inflammation modifies lipid-mediated renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

An update on the lipid nephrotoxicity hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Human mesangial cells express inducible macrophage scavenger receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Cell type-dependent variations in the subcellular distribution of alpha-mannosidase I and II

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Diabetes and advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

What is the consequence of an abnormal lipid profile in patients with type 2 diabetes or the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

Molecular mechanisms of diabetic nephropathy and its therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00646.2010

10.1152/AJPRENAL.00646.2010

21 January 2018

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018